Fidson Healthcare Plc (NGX: FIDSON)
Nigeria
· Delayed Price · Currency is NGN 14.00
-0.50 (-3.45%)
At close: Dec 24, 2024
Fidson Healthcare Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 72,406 | 53,050 | 40,634 | 30,861 | 18,276 | 14,062 | Upgrade
|
| Revenue Growth (YoY) | 46.04% | 30.56% | 31.67% | 68.86% | 29.97% | -13.36% | Upgrade
|
| Cost of Revenue | 42,882 | 32,260 | 23,667 | 16,061 | 10,047 | 8,472 | Upgrade
|
| Gross Profit | 29,523 | 20,790 | 16,967 | 14,800 | 8,229 | 5,590 | Upgrade
|
| Selling, General & Admin | 14,119 | 11,802 | 9,583 | 9,534 | 5,481 | 3,633 | Upgrade
|
| Other Operating Expenses | -576.1 | -488.78 | -783.26 | -513.29 | -340.96 | -287.33 | Upgrade
|
| Operating Expenses | 13,720 | 11,541 | 8,754 | 9,021 | 5,140 | 3,346 | Upgrade
|
| Operating Income | 15,803 | 9,249 | 8,213 | 5,779 | 3,089 | 2,244 | Upgrade
|
| Interest Expense | -4,424 | -2,102 | -1,773 | -1,222 | -1,334 | -1,735 | Upgrade
|
| Interest & Investment Income | 33.42 | 23.01 | 65.42 | 77.72 | 9.24 | 57.36 | Upgrade
|
| Currency Exchange Gain (Loss) | -5,651 | -1,261 | -758.6 | - | - | 3.09 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 5,761 | 5,909 | 5,747 | 4,634 | 1,764 | 569.45 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.56 | 8.29 | 34.23 | 83.26 | 8.79 | 6.22 | Upgrade
|
| Pretax Income | 5,763 | 5,917 | 5,781 | 4,718 | 1,773 | 575.67 | Upgrade
|
| Income Tax Expense | 2,285 | 2,310 | 1,594 | 997.73 | 567.76 | 168.48 | Upgrade
|
| Net Income | 3,478 | 3,608 | 4,187 | 3,720 | 1,205 | 407.19 | Upgrade
|
| Net Income to Common | 3,478 | 3,608 | 4,187 | 3,720 | 1,205 | 407.19 | Upgrade
|
| Net Income Growth | -19.47% | -13.84% | 12.56% | 208.70% | 195.94% | - | Upgrade
|
| Shares Outstanding (Basic) | 2,299 | 2,295 | 2,295 | 2,295 | 2,295 | 2,295 | Upgrade
|
| Shares Outstanding (Diluted) | 2,299 | 2,295 | 2,295 | 2,295 | 2,295 | 2,295 | Upgrade
|
| Shares Change (YoY) | 0.30% | - | 0.00% | - | -0.00% | 39.09% | Upgrade
|
| EPS (Basic) | 1.51 | 1.57 | 1.82 | 1.62 | 0.53 | 0.18 | Upgrade
|
| EPS (Diluted) | 1.51 | 1.57 | 1.82 | 1.62 | 0.53 | 0.18 | Upgrade
|
| EPS Growth | -19.71% | -13.84% | 12.56% | 208.70% | 195.94% | - | Upgrade
|
| Free Cash Flow | -20,188 | -2,898 | -2,873 | 2,234 | 897.42 | -638.24 | Upgrade
|
| Free Cash Flow Per Share | -8.78 | -1.26 | -1.25 | 0.97 | 0.39 | -0.28 | Upgrade
|
| Dividend Per Share | 0.600 | 0.600 | 0.550 | 0.455 | 0.227 | 0.136 | Upgrade
|
| Dividend Growth | 9.09% | 9.09% | 21.01% | 99.96% | 66.64% | 0% | Upgrade
|
| Gross Margin | 40.77% | 39.19% | 41.76% | 47.96% | 45.03% | 39.75% | Upgrade
|
| Operating Margin | 21.83% | 17.43% | 20.21% | 18.73% | 16.90% | 15.96% | Upgrade
|
| Profit Margin | 4.80% | 6.80% | 10.30% | 12.05% | 6.59% | 2.90% | Upgrade
|
| Free Cash Flow Margin | -27.88% | -5.46% | -7.07% | 7.24% | 4.91% | -4.54% | Upgrade
|
| EBITDA | 17,311 | 10,458 | 9,110 | 6,474 | 3,796 | 2,942 | Upgrade
|
| EBITDA Margin | 23.91% | 19.71% | 22.42% | 20.98% | 20.77% | 20.92% | Upgrade
|
| D&A For EBITDA | 1,508 | 1,209 | 897.42 | 695.39 | 707.12 | 697.87 | Upgrade
|
| EBIT | 15,803 | 9,249 | 8,213 | 5,779 | 3,089 | 2,244 | Upgrade
|
| EBIT Margin | 21.83% | 17.43% | 20.21% | 18.73% | 16.90% | 15.96% | Upgrade
|
| Effective Tax Rate | 39.65% | 39.03% | 27.58% | 21.15% | 32.03% | 29.27% | Upgrade
|
| Advertising Expenses | - | 1,183 | 1,400 | 663.26 | 340.99 | 231.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.